Zhou Xubin, Feng Shuaipeng, Xu Qingqing, Li Yian, Lan Jiaru, Wang Ziyi, Ding Yiduo, Wang Siling, Zhao Qinfu
Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning 110016, PR China.
School of Libra Arts of Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China.
Acta Biomater. 2025 Jan 1;191:1-28. doi: 10.1016/j.actbio.2024.11.023. Epub 2024 Nov 19.
Nanozymes are nano-catalysis materials with enzyme-like activities, which can repair the defects of natural enzyme such as harsh catalytic conditions, and harness their strengths to treat tumor. The emerging nanodynamic therapies improved drug selectivity and decreased drug tolerance, while causing efficient cell apoptosis through the generated reactive oxygen species (ROS). Nanodynamic therapies based on nanozymes can improve the complicated tumor microenvironment (TME) to reduce the defect rate of nanodynamic therapies, and provide more options for tumor treatment. This review summarized the characteristics and applications of nanozymes with different activities and the factors influencing the activity of nanozymes. We also focused on the application of nanozymes in nanodynamic therapies, including photodynamic therapy (PDT), chemodynamic therapy (CDT), and sonodynamic therapy (SDT). Moreover, we discussed the strategies for optimizing nanodynamic therapies based on nanozymes for tumor treatment in detail, and provided a systematic review of tactics for synergies with other tumor therapies. Ultimately, we analyzed the shortcomings of nanodynamic therapies based on nanozymes and the relevant research prospect, which would provide sufficient evidence and lay a foundation for further research. STATEMENT OF SIGNIFICANCE: 1. The novelty and significance of the work with respect to the existing literatures. (1) Recent advances in nanozyme-based nanodynamic therapies are comprehensively and systematically reviewed, and strategies to address the limitations and challenges of current therapies based on nanozymes are discussed firstly. (2) The mechanism of nanozymes in nanodynamic therapies is described for the first time. The synergistic therapies, prospects, and challenges of nanozyme-based nanodynamic therapies are innovatively discussed. 2. The scientific impact and interest to our readership. This review focuses on the recent progress of nanozyme-based nanodynamic therapies. This review indicates the way forward for the combined treatment of nanozymes and nanodynamic therapies, and lays a foundation for facilitating theoretical development in clinic.
纳米酶是一类具有类酶活性的纳米催化材料,可弥补天然酶如催化条件苛刻等缺陷,并发挥其优势用于肿瘤治疗。新兴的纳米动力疗法提高了药物选择性并降低了药物耐受性,同时通过产生活性氧(ROS)引发高效的细胞凋亡。基于纳米酶的纳米动力疗法可改善复杂的肿瘤微环境(TME),以降低纳米动力疗法的缺陷率,并为肿瘤治疗提供更多选择。本文综述了具有不同活性的纳米酶的特性与应用以及影响纳米酶活性的因素。我们还重点介绍了纳米酶在纳米动力疗法中的应用,包括光动力疗法(PDT)、化学动力疗法(CDT)和声动力疗法(SDT)。此外,我们详细讨论了基于纳米酶优化肿瘤纳米动力疗法的策略,并对与其他肿瘤疗法协同作用的策略进行了系统综述。最终,我们分析了基于纳米酶的纳米动力疗法的不足及相关研究前景,这将为进一步研究提供充分依据并奠定基础。重要性声明:1. 本研究相对于现有文献的新颖性和重要性。(1)全面系统地综述了基于纳米酶的纳米动力疗法的最新进展,并首次讨论了应对当前基于纳米酶疗法的局限性和挑战的策略。(2)首次阐述了纳米酶在纳米动力疗法中的作用机制。创新性地讨论了基于纳米酶的纳米动力疗法的协同治疗、前景及挑战。2. 对读者的科学影响和吸引力。本综述聚焦于基于纳米酶的纳米动力疗法的最新进展。本综述指明了纳米酶与纳米动力疗法联合治疗的方向,为推动临床理论发展奠定了基础。